Discovery of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases in Diverse Environmental Settings Suggests an Evolutionary Advantage Unrelated to Antibiotic Resistance
Type B dihydrofolate reductases (DfrB) are intrinsically highly resistant to the widely used antibiotic trimethoprim, posing a threat to global public health. The ten known DfrB family members have been strongly associated with genetic material related to the application of antibiotics. Several <...
Saved in:
Main Authors: | Stella Cellier-Goetghebeur (Author), Kiana Lafontaine (Author), Claudèle Lemay- (Author), Princesse Tsamo (Author), Alexis Bonneau-Burke (Author), Janine N. Copp (Author), Joelle N. Pelletier (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Bacterial Genomic Context of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases Highlights an Emerging Threat to Public Health
by: Claudèle Lemay-, et al.
Published: (2021) -
Antimicrobial resistance: An unrelenting enemy
by: Ameri M, et al.
Published: (2022) -
Analysis of the mechanisms of trimethoprim/sulfamethoxazole resistance in Staphylococcus aureus
by: T. Sato, et al.
Published: (2020) -
<it>Stenotrophomonas maltophilia </it>resistant to trimethoprim - sulfamethoxazole: an increasing problem
by: Al-Jasser Asma
Published: (2006) -
Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement; Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
by: Mireille Goetghebeur, et al.
Published: (2021)